The company has been bought and sold several times since the 1980s, and Mallinckrodt was most recently spun out as an ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Register now for our upcoming webinar, The Impact of M&A in MedTech, taking place September 26 at 12PM ET. Florence ...

The design details released today are for their PB560 model, which was originally launched in 2010 by a company called Covidien, before it merged with Medtronic, so we’re already starting with a ...

Register now for this month’s free webinar, The Impact of M&A in MedTech, taking place September 26 at 12PM ET. MedWorld ...

The company's focus on innovation ... share (“EPS”) growth has been inconsistent since 2015 when it acquired Covidien. It has been in the low single digits or flat for many years.

That is because the market will in some cases be willing to assign a higher multiple on earnings to a company that ... Medtronic acquired Ireland-based Covidien COV in 2015, it moved legal ...

In 2015, Medtronic, Inc. (the legacy NYSE-listed parent company, incorporated in Minnesota) acquired Ireland-based Covidien plc for cash and stock of $49.9 billion. The acquisition resulted in the ...

BlueWind Medical, a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi®, a patient-centric ...